123 related articles for article (PubMed ID: 8958650)
1. X-irradiation does not affect the levels of complement regulatory proteins, CD35 (CR1), CD55 (DAF) and CD59 on concentrated red cells.
Fukumori Y; Seya T; Ohnoki S; Shibata H; Yamaguchi H
Vox Sang; 1996; 71(4):243-4. PubMed ID: 8958650
[No Abstract] [Full Text] [Related]
2. Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis.
Núñez-López R; Escribano L; Schernthaner GH; Prados A; Rodríguez-González R; Díaz-Agustín B; López A; Hauswirth A; Valent P; Almeida J; Bravo P; Orfao A
Br J Haematol; 2003 Jan; 120(2):257-65. PubMed ID: 12542483
[TBL] [Abstract][Full Text] [Related]
3. Anaemia & expression levels of CD35, CD55 & CD59 on red blood cells in Plasmodium falciparum malaria patients from India.
Mahajan RC; Narain K; Mahanta J
Indian J Med Res; 2011 Jun; 133(6):662-4. PubMed ID: 21727667
[TBL] [Abstract][Full Text] [Related]
4. Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia.
Odhiambo CO; Otieno W; Adhiambo C; Odera MM; Stoute JA
BMC Med; 2008 Aug; 6():23. PubMed ID: 18717995
[TBL] [Abstract][Full Text] [Related]
5. Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies.
Hara T; Kojima A; Fukuda H; Masaoka T; Fukumori Y; Matsumoto M; Seya T
Br J Haematol; 1992 Oct; 82(2):368-73. PubMed ID: 1384649
[TBL] [Abstract][Full Text] [Related]
6. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
7. Isolation and functional assay of the membrane complement inhibitors CD55 (DAF) and CD59 (MIRL).
Parker CJ
Curr Protoc Immunol; 2001 May; Chapter 13():13.5.1-13.5.18. PubMed ID: 18432718
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometry and immunoblotting analysis of monoclonal antibodies directed to complement regulatory proteins.
Blanchard D; Navenot JM; Petit-Le Roux Y; Willem C; Loirat MJ
Transfus Clin Biol; 1997; 4(1):131-4. PubMed ID: 9095519
[TBL] [Abstract][Full Text] [Related]
9. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
[TBL] [Abstract][Full Text] [Related]
10. Distribution of C3-step regulatory proteins of the complement system, CD35 (CR1), CD46 (MCP), and CD55 (DAF), in hematological malignancies.
Seya T; Matsumoto M; Hara T; Hatanaka M; Masaoka T; Akedo H
Leuk Lymphoma; 1994 Feb; 12(5-6):395-400. PubMed ID: 7514063
[TBL] [Abstract][Full Text] [Related]
11. In vitro RBC exposure to Plasmodium falciparum has no effect on RBC antigen expression.
Chambers DR; Procter J; Muratova O; Byrne K; Keister D; Shanks D; Magill A; Stroncek D
Transfus Med; 2002 Jun; 12(3):213-9. PubMed ID: 12071878
[TBL] [Abstract][Full Text] [Related]
12. Reduction in erythrocyte complement receptor 1 (CR1, CD35) and decay accelerating factor (DAF, CD55) during normal pregnancy.
Imrie HJ; McGonigle TP; Liu DT; Jones DR
J Reprod Immunol; 1996 Oct; 31(3):221-7. PubMed ID: 8905554
[TBL] [Abstract][Full Text] [Related]
13. Quantification of the CD55 and CD59, membrane inhibitors of complement on HIV-1 particles as a function of complement-mediated virolysis.
Nakamura M; Okada H; Sasaki H; Yoshida K; Kamada M; Okada N; Terada M; Ohno T
Microbiol Immunol; 1996; 40(8):561-7. PubMed ID: 8887350
[TBL] [Abstract][Full Text] [Related]
14. Complement-regulatory protein expression and activation of complement cascade on erythrocytes from patients with rheumatoid arthritis (RA).
Arora M; Kumar A; Das SN; Srivastava LM
Clin Exp Immunol; 1998 Jan; 111(1):102-6. PubMed ID: 9472668
[TBL] [Abstract][Full Text] [Related]
15. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
Terstappen LW; Nguyen M; Lazarus HM; Medof ME
J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
[TBL] [Abstract][Full Text] [Related]
16. Different expression and mobilisation of the complement regulatory proteins CD35, CD55 and CD59 in neonatal and adult neutrophils.
Lothian C; Dahlgren C; Lagercrantz H; Lundahl J
Biol Neonate; 1997; 72(1):15-21. PubMed ID: 9313830
[TBL] [Abstract][Full Text] [Related]
17. Detection of complement regulatory proteins on soft contact lenses.
Bardenstein DS; Sauer S; Szczotka L; Medof ME
Curr Eye Res; 1997 Dec; 16(12):1270-3. PubMed ID: 9426963
[TBL] [Abstract][Full Text] [Related]
18. High expression of CD59 and CD55 on benign and malignant plasma cells.
Alcindor T; Kimlinger T; Witzig TE
Leuk Lymphoma; 2006 May; 47(5):919-21. PubMed ID: 16753879
[No Abstract] [Full Text] [Related]
19. Knock out of alpha1,3-galactosyltransferase or expression of alpha1,2-fucosyltransferase further protects CD55- and CD59-expressing mouse hearts in an ex vivo model of xenograft rejection.
Cowan PJ; Chen CG; Shinkel TA; Fisicaro N; Salvaris E; Aminian A; Romanella M; Pearse MJ; d'Apice AJ
Transplantation; 1998 Jun; 65(12):1599-604. PubMed ID: 9665076
[TBL] [Abstract][Full Text] [Related]
20. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.
Barros MM; Yamamoto M; Figueiredo MS; Cançado R; Kimura EY; Langhi DM; Chiattone CS; Bordin JO
Transfusion; 2009 Jan; 49(1):154-60. PubMed ID: 18954403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
